The Fifth Sense: Mechanosensory Regulation of Alpha-actinin-4 and Its Relevance for Cancer Metastasis
Overview
Reproductive Medicine
Authors
Affiliations
Metastatic cancer cells invading through dense tumor stroma experience internal and external forces that are sensed through a variety of mechanosensory proteins that drive adaptations for specific environments. Alpha-actinin-4 (ACTN4) is a member of the α-actinin family of actin crosslinking proteins that is upregulated in several types of cancers. It shares 86% protein similarity with α-actinin-1, another non-muscle ACTN isoform, which appears to have a more modest role, if any, in cancer progression. While they share regulatory mechanisms, such as phosphorylation, calcium binding, phosphatidyl inositol binding, and calpain cleavage, α-actinin-4 exhibits a unique mechanosensory regulation that α-actinin-1 does not. This behavior is mediated, at least in part, by each protein's actin-binding affinity as well as the catch-slip-bond behavior of the actin binding domains. We will discuss currently known modes of ACTN4 regulation, their interactions, and how mechanosensation may provide major therapeutic targeting potential for cancer metastasis.
From stress fiber to focal adhesion: a role of actin crosslinkers in force transmission.
Katsuta H, Sokabe M, Hirata H Front Cell Dev Biol. 2024; 12:1444827.
PMID: 39193363 PMC: 11347286. DOI: 10.3389/fcell.2024.1444827.
Guo Q, Zhang G, Zhou W, Lu Y, Chen X, Deng Z MedComm (2020). 2024; 5(6):e547.
PMID: 38764726 PMC: 11099756. DOI: 10.1002/mco2.547.
Role of a Pdlim5:PalmD complex in directing dendrite morphology.
Srivastava Y, Donta M, Mireles L, Paulucci-Holthauzen A, Waxham M, McCrea P Front Cell Neurosci. 2024; 18:1315941.
PMID: 38414752 PMC: 10896979. DOI: 10.3389/fncel.2024.1315941.
Liu P, Liu S, Zhu C, Li Y, Li Y, Fei X Front Oncol. 2023; 13:1169833.
PMID: 37207150 PMC: 10189038. DOI: 10.3389/fonc.2023.1169833.
Cytoskeletal and Cytoskeleton-Associated Proteins: Key Regulators of Cancer Stem Cell Properties.
Li Y, Wang D, Ge H, Gungor C, Gong X, Chen Y Pharmaceuticals (Basel). 2022; 15(11).
PMID: 36355541 PMC: 9698833. DOI: 10.3390/ph15111369.